TapImmune (TPIV) Stock Price, News & Analysis

Company Overview

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Key Stats

• Today's Range: $8.01 to $8.40
• 50-Day Range: $8.34 to $8.34
• 52-Week Range: $2.58 to $13.55
• Volume: 100,653 shs
• Average Volume: 235,808 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TPIV Stock Analysis - Frequently Asked Questions

How were TapImmune's earnings last quarter?

TapImmune, Inc. (NASDAQ:TPIV) released its earnings results on Thursday, August, 9th. The company reported ($0.41) earnings per share for the quarter. The business earned $0.21 million during the quarter.

What other stocks do shareholders of TapImmune own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TapImmune investors own include Verastem (VSTM), Viking Therapeutics (VKTX), Coherus BioSciences (CHRS), Portola Pharmaceuticals (PTLA), Rigel Pharmaceuticals (RIGL), Fate Therapeutics (FATE) and Galectin Therapeutics (GALT).

Company Calendar

• Last Earnings: 8/09/2018
• Today: 5/13/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TPIV
• CIK: 1094038
• Web: www.tapimmune.com
• Phone: (713) 400-6400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A